Correlation Between Zentalis Pharmaceuticals and CannBioRx Life

Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and CannBioRx Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and CannBioRx Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and CannBioRx Life Sciences, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and CannBioRx Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of CannBioRx Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and CannBioRx Life.

Diversification Opportunities for Zentalis Pharmaceuticals and CannBioRx Life

-0.31

Correlation Coefficient

Zentalis Pharmaceuticals  CannBioRx Life

Very good diversification

The 3 months correlation between Zentalis and CannBioRx is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and CannBioRx Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CannBioRx Life Sciences and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with CannBioRx Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CannBioRx Life Sciences has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and CannBioRx Life go up and down completely randomly.

Pair Corralation between Zentalis Pharmaceuticals and CannBioRx Life

Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the CannBioRx Life. But the stock apears to be less risky and, when comparing its historical volatility, Zentalis Pharmaceuticals Llc is 3.22 times less risky than CannBioRx Life. The stock trades about -0.05 of its potential returns per unit of risk. The CannBioRx Life Sciences is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  0.71  in CannBioRx Life Sciences on September 18, 2024 and sell it today you would earn a total of  0.11  from holding CannBioRx Life Sciences or generate 15.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Zentalis Pharmaceuticals Llc  vs.  CannBioRx Life Sciences

Zentalis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zentalis Pharmaceuticals Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

CannBioRx Life Sciences

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in CannBioRx Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal technical and fundamental indicators, CannBioRx Life showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Zentalis Pharmaceuticals and CannBioRx Life

The main advantage of trading using opposite Zentalis Pharmaceuticals and CannBioRx Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, CannBioRx Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CannBioRx Life will offset losses from the drop in CannBioRx Life's long position.

The idea behind Zentalis Pharmaceuticals Llc and CannBioRx Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.